Fig. 1 · Structure
Documents & Downloads
Itazigrel
Antiplatelet Agent
Itazigrel is an orally active antiplatelet agent that primarily targets cyclooxygenase activity. By inhibiting this enzyme, Itazigrel effectively reduces platelet aggregation, making it useful in research related to thrombus formation and cardiovascular diseases. This compound is valuable for studies investigating antiplatelet therapies and their mechanistic roles in preventing vascular events.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 70529-35-0 |
| Applications | Antiplatelet Agent |
| Formula | C18H14F3NO2S |
| Molecular Weight | 365.37 |
| Synonyms | U-53059 |
| SMILES | FC(C1=NC(C2=CC=C(OC)C=C2)=C(C3=CC=C(OC)C=C3)S1)(F)F |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.